Microbot Medical Inc. logo

MBOT Earnings Date: Nov 11, 2026 (Estimated) — Microbot Medical Inc.

NASDAQ · Healthcare · Medical Instruments & Supplies

Updated

Price $1.08
Market Cap $72.9M
P/E -3.7
52W Range $0.93 – $2.85
Next Earnings · After close (est.)

When is MBOT's next earnings date?

Microbot Medical Inc. (MBOT) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.08 on revenue of $8,500.

How did MBOT do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Microbot Medical Inc. posted EPS of -$0.08 versus the -$0.07 estimate, a miss of 0.0%. Revenue was $241,000 against a $133,333 estimate. The stock's 1-day post-earnings move was -13.2%.

How much does MBOT stock move after earnings?

MBOT beat EPS estimates in 2 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 6.9% (up or down) in the day after earnings.

About Microbot Medical Inc.

Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.07-0.08+0.00%$241,000❌ Miss-13.18%-21.96%-24.55%
2026-05-13Q1 2026-0.07-0.05+28.57%$105,000✅ Beat-14.75%-19.82%-17.97%
2026-03-26Q4 2025-0.06-0.04+33.33%$0✅ Beat-8.78%-8.40%-17.18%
2025-11-12Q3 2025-0.03-0.07-133.33%$0❌ Miss-6.13%-9.43%+13.68%
2025-08-12Q2 2025-0.08-0.10-25.00%$0❌ Miss-2.56%-0.96%+24.68%
2025-03-25Q4 2024—-0.19—$0—-4.40%-6.29%+52.83%
2024-11-13Q3 2024-0.17-0.20-17.65%$0❌ Miss-4.71%-7.72%+0.30%
2024-08-14Q2 2024-0.17-0.17+0.00%$0➖ Inline+1.01%+5.05%+0.00%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .